Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Surzebiclimab by BeiGene for Advanced Malignancy: Likelihood of Approval
Surzebiclimab is under clinical development by BeiGene and currently in Phase III for Advanced Malignancy. According to GlobalData, Phase III...
Data Insights
Surzebiclimab by BeiGene for Solid Tumor: Likelihood of Approval
Surzebiclimab is under clinical development by BeiGene and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...